title: Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate.
abstract: Vaccination is considered the most cost-effective approach to preventing infectious diseases, yet better formulations and delivery methods for efficient distribution and administration of vaccines are needed, especially for low-resource settings. A fast-dissolving tablet (FDT) that could be packaged in a compact stackable blister sheet is a potentially attractive option for formulating oral vaccines, since it would minimally impact the cold chain and could potentially be administered directly to patients without reconstitution. This study focused on using one component of a live attenuated trivalent vaccine under development to produce a FDT for the prevention of diarrhea induced by enterotoxigenic Escherichia coli (ETEC). Ten formulations were prepared and freeze dried to produce FDTs. Three freezing conditions were explored, along with different drying and package sealing methods. Physical properties examined included structural integrity, dissolution time, moisture content, and glass transition temperature. Bacterial viability was tested by assaying for colony-forming units. The formulation compositions and freeze-drying parameters were adjusted in an iterative process to arrive at a promising formulation for the ETEC vaccine tablet. This formulation included sucrose and trehalose as cryoprotectants; phosphate and glutamate salts as buffers and stabilizers; and Natrosol(®), polyvinylpyrrolidone, and mannitol as binders. The process loss in viability during freeze drying was less than 0.3 log 10 (50% recovery) for the optimized vaccine tablet formulation. The final tablets were robust, disintegrated in less than 10s, and preserved the bacteria at 2-8°C for at least 12 months with less than 0.4 log 10 loss (40% recovery) in viability during storage. This study indicates that the FDT produced by freeze drying directly in a blister sheet could be a practical option for formulating ETEC vaccines for oral immunization and help to facilitate delivery of lifesaving vaccines, particularly in low-resource settings.
authors: PATH, PO Box 900922, Seattle, WA 98121, USA. Electronic address: mlal@path.org.
authors: Manjari
authors: M
authors: Lal
authors: Scott
authors: S
authors: Priddy
authors: Lou
authors: L
authors: Bourgeois
authors: Richard
authors: R
authors: Walker
authors: Walt
authors: W
authors: Pebley
authors: James
authors: J
authors: Brown
authors: James
authors: J
authors: Desai
authors: Michael J
authors: MJ
authors: Darsley
authors: Debra
authors: D
authors: Kristensen
authors: Dexiang
authors: D
authors: Chen
mesh_terms: D000284:Administration, Oral; D002626:Chemistry, Pharmaceutical; D003967:Diarrhea / Q000517:prevention & control; D004337:Drug Carriers / Q000008:administration & dosage; D004355:Drug Stability; D054307:Enterotoxigenic Escherichia coli / Q000235:genetics / Q000276:immunology*; D004927:Escherichia coli Infections / Q000517:prevention & control; D022361:Escherichia coli Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D005612:Freeze Drying; D006801:Humans; D050296:Microbial Viability; D013607:Tablets / Q000008:administration & dosage*; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology
chemical_list: D004337:Drug Carriers; D022361:Escherichia coli Vaccines; D013607:Tablets; D014613:Vaccines, Attenuated
keywords: ETEC; FDT; Fast-dissolving tablet; Freeze-dried vaccines; Live attenuated vaccines; Oral immunization; Tg; enterotoxigenic Escherichia coli; fast-dissolving tablet; glass transition temperature